Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds
AssigneePfizer Inc.
InventorsMark A. Haxell, David A. Perry, Hiroshi Maeda, Junsuke Tone
Life of this patent
Estimating the term…
Abstract
The present invention relates to certain antibiotic compounds, designated N787-182 compounds herein and derivatives thereof, which are antiparasitic agents, active against insect pests, acari, free-living nematodes and endo- and ectoparasites. This invention also relates to pharmaceutical and other compositions containing such compounds, methods of using such compounds, the microorganism Streptomyces hygroscopicus ATCC 53718 and mutants or genetically transformed or recombinant form thereof, and processes for producing such compounds.
Claims2
A biologically pure culture of Streptomyces hygroscopicus having all of the identifying characteristics of ATCC 53718 or a mutant thereof capable of producing a compound of the formula ##STR2## wherein R is H;
- R.sup.1 is H or OCOCH(CH.sub.3).sub.2 ;
- R.sup.2 is OH;
- and
- R.sup.3 is H or OCOCH(CH.sub.3).sub.2 ;
- and R.sup.1 and R.sup.3 may not both be H,
- upon cultivation in an aqueous nutrient medium containing assimilable sources of carbon, nitrogen and inorganic salts.
A biologically pure culture of Streptomyces hygroscopicus ATCC 53718.
Dependencies are inferred from the claim text.